Showing 80,241 - 80,260 results of 124,410 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.33s Refine Results
  1. 80241

    Waterfall plot showing the quantitative changes in ER, PR, and Ki-67 expression. by Yuqin Ding (623253)

    Published 2020
    “…(A) ER discordance rate: 10.4% (50/482) of patients, including 36 (7.5%) patients with positive-to-negative conversion and 14 (2.9%) patients with negative-to-positive conversion; (B) PR discordance rate: 17.0% (82/482) of patients, including 57 (11.8%) patients with positive-to-negative conversion and 25 (5.2%) patients with negative-to-positive conversion; (C) Ki-67 discordance rates: 50.4% (243/448) of patients had decreased expression and 27.0% (130/448) of patients had increased expression.…”
  2. 80242

    IL-1β depletion and IL-1 receptor antagonist treatment alleviated the neutrophilic inflammation. by Wen-Cheng Chao (2817868)

    Published 2017
    “…<p>The characteristic pulmonary histopathological images (A) of <i>M</i>. <i>marinum</i>-infected <i>Ncf1</i><sup><i>-/-</i></sup> mice and WT mice on day-5 with and without IL-1β depletion by a monoclonal antibody directed against IL-1β (150μg on day-1). …”
  3. 80243

    Adaptation period to diets with low or high fiber on digetibility and faecal characteristics in dogs by T. Ramos (7501706)

    Published 2019
    “…Fecal consistency of the dogs did not differ among diets and periods (P> 0.05). There was a decrease in fecal pH and ammonia in dogs fed the diet with 15% SH (P< 0.05) after 10 days of feeding (P< 0.05). …”
  4. 80244

    Artifacts in FRAP arising from the strength of the intentional photobleach. by Tatsuya Morisaki (631489)

    Published 2014
    “…Artifactual recoveries were observed with the GFP tag (A) but not the TMR-Halo tag (B). Consistent with previous studies <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0107730#pone.0107730-Mueller2" target="_blank">[9]</a>, the relative size of the recovery with the GFP-tag increased with decreasing strength of the photobleach (colored curves in A). …”
  5. 80245

    <i>In vivo</i> luciferase detection of hAFSC in ATN damaged kidneys. by Laura Perin (252948)

    Published 2010
    “…The optical signal is strongly present during the first 5 hours post injection (panel 2–5), decreases over time (panel 6–8), but is still present after 21 days (panel 9). …”
  6. 80246

    Isolation and characterization of brain derived EVs. by Sowmya V. Yelamanchili (482686)

    Published 2015
    “…Analysis revealed significantly increased expression of miR-21-5p, miR-100-5p and miR-146-5p, and decreased expression miR-126-5p, in SIVE. …”
  7. 80247

    RSK2 regulates DNA repair efficiency under conditions of genotoxic stress. by Han Chi Lim (439624)

    Published 2013
    “…<p>A. Increased formation of AD-induced γH2AX foci in RSK2 KO MEFs. …”
  8. 80248

    Only spaced (but not massed) learning allowed long-term retention of an associative olfactory task and increased neurogenesis. by Florence Kermen (362513)

    Published 2013
    “…<p><b>A</b>. Experimental design. For the spaced conditioning (<b>Ai</b>) BrdU was injected 14 days prior to training which occurred over 5 days (4 trials per day). …”
  9. 80249

    The NK1-receptor antagonist ezlopitant significantly inhibits both sucrose and ethanol operant self-administration in rats. by Pia Steensland (362091)

    Published 2013
    “…<p>Ezlopitant (2, 5, 10 mg/kg i.p.) dose dependently decreases self-administration of 5% sucrose (<b>A</b>). …”
  10. 80250

    Image2_Arnica Montana L. Supercritical Extraction Optimization for Antibiotic and Anticancer Activity.JPEG by Taja Žitek (12521470)

    Published 2022
    “…The content of proanthocyanidins was highest at a pressure between 18 and 24 MPa. The extracts inhibited three different microorganisms successfully; Staphylococcus aureus, Escherichia coli and Candida albicans, at concentrations ranging from 0.1 to 5.16 mg/ml and showed anticancer activity decrease up to 85% at a concentration of 0.5 mg/ml.…”
  11. 80251

    Image1_Arnica Montana L. Supercritical Extraction Optimization for Antibiotic and Anticancer Activity.JPEG by Taja Žitek (12521470)

    Published 2022
    “…The content of proanthocyanidins was highest at a pressure between 18 and 24 MPa. The extracts inhibited three different microorganisms successfully; Staphylococcus aureus, Escherichia coli and Candida albicans, at concentrations ranging from 0.1 to 5.16 mg/ml and showed anticancer activity decrease up to 85% at a concentration of 0.5 mg/ml.…”
  12. 80252

    Evaluation of paralysis time and animal behavior in the open field. by Sunamita de Carvalho Lima (5598089)

    Published 2018
    “…The last bar in panel A, indicated by the 24 h in the open box, refers to the <i>ip</i> administration of same dose of crotamine (7.5 μg/animal or 0.3 mg/kg BW) in the same animal 24 h after first crotamine administration, showing a significant decrease in the time for paralysis onset compared to the first administration of crotamine in naïve animal, a day before. …”
  13. 80253

    Systemic status of WT and miR-150 null mutant (miR-150<sup>-/-</sup>) mice with normal chow diet or HFD. by Liheng Shi (144105)

    Published 2016
    “…There is no statistical interaction between miR-150 null mutation and HFD regimen (2-way ANOVA). n = 5 for each group. (C) Wild type mice fed with HFD have a significant decrease of miR-150 expression compared to mice fed with normal diet (Normal; student’s <i>t</i>-test). …”
  14. 80254

    T-helper cell pathway diagram. by Josephine S. D’Alessandro (814578)

    Published 2015
    “…Gray lines indicate members of a group. APCs, antigen-presenting cells; CXCR1, chemokine (C-X-C motif) receptor 1; CXCR3, chemokine (C-X-C motif) receptor 3; CXCR5, chemokine (C-X-C motif) receptor 5; CXCL10, chemokine (C-X-C motif) ligand 10; GA, glatiramer acetate; HLADMA, major histocompatibility complex class II, DM alpha; HLADMB, major histocompatibility complex class II, DM beta; HLADQB1, major histocompatibility complex class II, DQ beta 1; ICOSLG, inducible T-cell costimulatory ligand; IL-4, interleukin-4; MHC class II, major histocompatibility complex class II; LTB, lymphotoxin beta (tumor necrosis factor superfamily, member 3); MYD, myeloid differentiation primary response protein; S100A10, S100 calcium-binding protein A10; STAT, signal transducer and activator of transcription; TCR, T-cell receptor; Th, T-helper.…”
  15. 80255
  16. 80256
  17. 80257

    Investigating the Effect of Different Treatments with Lactic Acid Bacteria on the Fate of <i>Listeria monocytogenes</i> and <i>Staphylococcus aureus</i> Infection in <i>Galleria me... by Athena Grounta (3115224)

    Published 2016
    “…It was observed that the time (6 or 24 h) and type (live or heat-killed cells) of challenge period with LAB prior to infection greatly affected the survival of infected larvae. The highest decrease of <i>L</i>. <i>monocytogenes</i> population in the hemolymph was observed in groups challenged for 6 h with heat-killed cells by an average of 1.8 log units compared to non challenged larvae for strains B281 (<i>p</i> 0.0322), B282 (<i>p</i> 0.0325), and LGG (<i>p</i> 0.0356). …”
  18. 80258

    Multisite Phosphorylation Provides an Effective and Flexible Mechanism for Switch-Like Protein Degradation by S. Marjan Varedi K. (235441)

    Published 2010
    “…A single-site protein cannot convert a graded input of kinase increase to much sharper output, whereas multisite phosphorylation is capable of generating a highly switch-like temporal profile of the substrate protein with two characteristics: a temporal threshold and rapid decrease beyond the threshold. …”
  19. 80259

    Redox status of rat cortical neurons. by Inmaculada Posadas (218859)

    Published 2013
    “…V stands for vehicle (DMSO 1‰)-treated cells. Data represent the mean ± SEM of 9 independent experiments. ***, p<i><</i>0.001 as compared to vehicle-treated cells (V); <sup>###</sup>, p<i><</i>0.001 compared to AAP 2 mM (A2). …”
  20. 80260

    Citalopram does not increase neural signals for reward or effort outcomes. by Jacqueline Scholl (3752851)

    Published 2017
    “…On the contrary, a more lenient time point—by—time point <i>t</i> test analysis of the time courses revealed that in striatum and vmPFC, citalopram, in fact, decreased the relative reward magnitude outcome signal late in the outcome phase (*<i>p</i> < 0.05 for time point—by—time point two-sided <i>t</i> tests). …”